Bioxytran, Inc.
BIXT0.02389.17% ( +0.0020 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Bioxytran, Inc.(BIXT) the EBIT is -1.935 M (-274.3%);the EPS is -0.0184 (-20.94%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B274.31%
----
----
EPS
-0.018420.94%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf